Investigation of Molecular Properties of Antiretroviral Agents to Enhance CNS Penetration Abilities for the Treatment of Cognitive Impairment in HIV-Associated Neurocognitive Disorder
- 23 June 2020
- journal article
- editorial
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 11 (14) , 2034-2038
Abstract
HIV-associated neurocognitive disorder (HAND) can be represented by neurological and neuropathological abnormalities with a consequence of motor and cognitive loss. It has become a critical unmet medical need for infected people, and the number continues to rise every year. Pathological investigations have revealed its occurrence due to the release of free radicals from the HIV infected microglia and macrophages. So far, no effective clinical trials have been conducted for its treatment other than the use of some antiretroviral therapies which have failed to show good results due to poor CNS penetration and hence low CNS distribution. This collective information from the updated literature reports motivated us to share the idea of conjugated products of antiretroviral agents and antioxidants leading to better brain penetration abilities due to higher log p values, higher molecular weight and possibly low toxicity and better neuroprotective action. In this Viewpoint, we have attempted to analyze the chemical and pharmacological classes of antiretroviral agents (ARAs) and their clinical failures for the treatment of cognitive dysfunction due to HIV infection. As the causes of clinical insufficiency of antiretroviral agents and neuropathological mechanisms of HAND have been well established, it would be a good opportunity for medicinal chemists to develop new potential antiretroviral agents or to improve their molecular properties for better therapeutic implications. Furthermore, in silico based molecular properties have been investigated correlating them to the brain penetration abilities.Keywords
This publication has 6 references indexed in Scilit:
- ZIDOVUDINE: STRUCTURAL MODIFICATIONS AND THEIR IMPACT ON BIOLOGICAL ACTIVITIES AND PHARMACOKINETIC PROPERTIESJournal of the Chilean Chemical Society, 2019
- Controversies in HIV-associated neurocognitive disordersThe Lancet Neurology, 2014
- The discovery and development of new potential antioxidant agents for the treatment of neurodegenerative diseasesExpert Opinion on Drug Discovery, 2014
- Human immunodeficiency virus‐associated neurocognitive disorders: Mind the gapAnnals of Neurology, 2010
- Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidantsTrends in Neurosciences, 2001
- The role of phagocytes in HIV-related oxidative stressJournal of Clinical Virology, 2001